Biosenic SA

Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004

29 Aug 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics strengthens its financial structure with the implementation of its financing agreement with the European Investment Bank and the reception of a disbursement offer for the first tranche of €8.0 million

27 Aug 2021 12:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics SA: Notice of Extraordinary Shareholders’ Meeting on 23 August 2021

05 Aug 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017

27 Jul 2021 10:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics provides update on the progress of clinical studies

18 Jul 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medical Officer

11 Jul 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics SA: Notice of Extraordinary Shareholders’ Meeting on 5 August 2021

04 Jul 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics secures up to €16 million loan financing from the European Investment Bank to accelerate ongoing clinical and commercial development of innovative orthopedic treatment

30 Jun 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics publishes results of ALLOB Phase I/IIa study for the treatment of delayed-union fractures in Stem Cell Research & Therapy

29 Jun 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics announces Annual General Meeting results

09 Jun 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics Provides First Quarter 2021 Business Update

25 May 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics to participate in upcoming conferences

19 May 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics to host Annual General Meeting on 9 June 2021

06 May 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics announces 2020 full year results

28 Apr 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics appoints industry cell therapy expert, Anthony Ting, PhD as Chief Scientific Officer

29 Mar 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference

16 Mar 2021 23:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics SA: Notice of Extraordinary Shareholders’ Meeting on 26 February 2021

08 Feb 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook

19 Jan 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

13 Jan 2021 22:00:00 By Nasdaq GlobeNewswire

Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study

11 Jan 2021 22:00:00 By Nasdaq GlobeNewswire